APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclin Dependent Kinase 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyclin Dependent Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025182 pages

Choose your research edition.

Industry ResearchCyclin Dependent Kinase 1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclin Dependent Kinase 1 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cyclin Dependent Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclin Dependent Kinase 1 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclin Dependent Kinase 1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyclin Dependent Kinase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclin Dependent Kinase 1 include Tragara Pharmaceuticals Inc, Tiziana Life Sciences Plc, Presage Biosciences Inc, ChoDang Pharm Co Ltd and Astex Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyclin Dependent Kinase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyclin Dependent Kinase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyclin Dependent Kinase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclin Dependent Kinase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyclin Dependent Kinase 1 Segment by Company

Tragara Pharmaceuticals Inc

Tiziana Life Sciences Plc

Presage Biosciences Inc

ChoDang Pharm Co Ltd

Astex Pharmaceuticals Inc

Cyclin Dependent Kinase 1 Segment by Type

Milciclib

CD-650

AT-7519

Others

Cyclin Dependent Kinase 1 Segment by Application

Relapsed Chronic Lymphocytic Leukemia

Lymphoma

Gliosarcoma

Others

Cyclin Dependent Kinase 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclin Dependent Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclin Dependent Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclin Dependent Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclin Dependent Kinase 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclin Dependent Kinase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cyclin Dependent Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cyclin Dependent Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cyclin Dependent Kinase 1 Industry Trends Table 2. Cyclin Dependent Kinase 1 Industry Drivers Table 3. Cyclin Dependent Kinase 1 Industry Opportunities and Challenges Table 4. Cyclin Dependent Kinase 1 Industry Restraints Table 5. Global Cyclin Dependent Kinase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyclin Dependent Kinase 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cyclin Dependent Kinase 1 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers Table 9. Global Cyclin Dependent Kinase 1 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Cyclin Dependent Kinase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyclin Dependent Kinase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyclin Dependent Kinase 1 Manufacturers, Product Type & Application Table 13. Global Cyclin Dependent Kinase 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyclin Dependent Kinase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Milciclib Table 17. Major Manufacturers of CD-650 Table 18. Major Manufacturers of AT-7519 Table 19. Major Manufacturers of Others Table 20. Global Cyclin Dependent Kinase 1 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 22. Global Cyclin Dependent Kinase 1 Sales by Type (2027-2032) & (k units) Table 23. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2021-2026) Table 24. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2027-2032) Table 25. Global Cyclin Dependent Kinase 1 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Cyclin Dependent Kinase 1 Revenue by Type (2021-2026) & (k units) Table 27. Global Cyclin Dependent Kinase 1 Revenue by Type (2027-2032) & (k units) Table 28. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2021-2026) Table 29. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Relapsed Chronic Lymphocytic Leukemia Table 31. Major Manufacturers of Lymphoma Table 32. Major Manufacturers of Gliosarcoma Table 33. Major Manufacturers of Others Table 34. Global Cyclin Dependent Kinase 1 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 36. Global Cyclin Dependent Kinase 1 Sales by Application (2027-2032) & (k units) Table 37. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2021-2026) Table 38. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2027-2032) Table 39. Global Cyclin Dependent Kinase 1 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Cyclin Dependent Kinase 1 Revenue by Application (2021-2026) & (k units) Table 41. Global Cyclin Dependent Kinase 1 Revenue by Application (2027-2032) & (k units) Table 42. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2021-2026) Table 43. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2027-2032) Table 44. Global Cyclin Dependent Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Cyclin Dependent Kinase 1 Sales by Region (2021-2026) & (k units) Table 46. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2021-2026) Table 47. Global Cyclin Dependent Kinase 1 Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Cyclin Dependent Kinase 1 Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 51. North America Cyclin Dependent Kinase 1 Sales by Country (2027-2032) & (k units) Table 52. Europe Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 54. Europe Cyclin Dependent Kinase 1 Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Cyclin Dependent Kinase 1 Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2027-2032) & (k units) Table 61. Global Cyclin Dependent Kinase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Cyclin Dependent Kinase 1 Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Cyclin Dependent Kinase 1 Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2021-2026) Table 65. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2027-2032) Table 66. Tragara Pharmaceuticals Inc Company Information Table 67. Tragara Pharmaceuticals Inc Business Overview Table 68. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 70. Tragara Pharmaceuticals Inc Recent Development Table 71. Tiziana Life Sciences Plc Company Information Table 72. Tiziana Life Sciences Plc Business Overview Table 73. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio Table 75. Tiziana Life Sciences Plc Recent Development Table 76. Presage Biosciences Inc Company Information Table 77. Presage Biosciences Inc Business Overview Table 78. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio Table 80. Presage Biosciences Inc Recent Development Table 81. ChoDang Pharm Co Ltd Company Information Table 82. ChoDang Pharm Co Ltd Business Overview Table 83. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio Table 85. ChoDang Pharm Co Ltd Recent Development Table 86. Astex Pharmaceuticals Inc Company Information Table 87. Astex Pharmaceuticals Inc Business Overview Table 88. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 90. Astex Pharmaceuticals Inc Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Cyclin Dependent Kinase 1 Distributors List Table 94. Cyclin Dependent Kinase 1 Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Cyclin Dependent Kinase 1 Product Image Figure 2. Global Cyclin Dependent Kinase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclin Dependent Kinase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclin Dependent Kinase 1 Sales (2021-2032) & (k units) Figure 5. Global Cyclin Dependent Kinase 1 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cyclin Dependent Kinase 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Milciclib Image Figure 9. CD-650 Image Figure 10. AT-7519 Image Figure 11. Others Image Figure 12. Global Cyclin Dependent Kinase 1 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Cyclin Dependent Kinase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2021-2032) Figure 15. Global Cyclin Dependent Kinase 1 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Cyclin Dependent Kinase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2021-2032) Figure 18. Relapsed Chronic Lymphocytic Leukemia Image Figure 19. Lymphoma Image Figure 20. Gliosarcoma Image Figure 21. Others Image Figure 22. Global Cyclin Dependent Kinase 1 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Cyclin Dependent Kinase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2021-2032) Figure 25. Global Cyclin Dependent Kinase 1 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Cyclin Dependent Kinase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2021-2032) Figure 28. North America Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2032) Figure 30. U.S. Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2032) Figure 35. Germany Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2032) Figure 42. China Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2032) Figure 50. Brazil Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Cyclin Dependent Kinase 1 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Cyclin Dependent Kinase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Cyclin Dependent Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 61. North America Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Cyclin Dependent Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 63. Europe Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Cyclin Dependent Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Cyclin Dependent Kinase 1 Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Cyclin Dependent Kinase 1 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Cyclin Dependent Kinase 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Milciclib
  • CD-650
  • AT-7519
  • Others
Applications
  • Relapsed Chronic Lymphocytic Leukemia
  • Lymphoma
  • Gliosarcoma
  • Others
Companies covered
  • Tragara Pharmaceuticals Inc
  • Tiziana Life Sciences Plc
  • Presage Biosciences Inc
  • ChoDang Pharm Co Ltd
  • Astex Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cyclin Dependent Kinase 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cyclin Dependent Kinase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cyclin Dependent Kinase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cyclin Dependent Kinase 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cyclin Dependent Kinase 1 Market Dynamics
  1. 2.1 Cyclin Dependent Kinase 1 Industry Trends
  2. 2.2 Cyclin Dependent Kinase 1 Industry Drivers
  3. 2.3 Cyclin Dependent Kinase 1 Industry Opportunities and Challenges
  4. 2.4 Cyclin Dependent Kinase 1 Industry Restraints
3 Cyclin Dependent Kinase 1 Market by Manufacturers
  1. 3.1 Global Cyclin Dependent Kinase 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cyclin Dependent Kinase 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cyclin Dependent Kinase 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyclin Dependent Kinase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclin Dependent Kinase 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyclin Dependent Kinase 1 Manufacturers, Product Type & Application
  7. 3.7 Global Cyclin Dependent Kinase 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclin Dependent Kinase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclin Dependent Kinase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclin Dependent Kinase 1 Tier 1, Tier 2, and Tier 3
4 Cyclin Dependent Kinase 1 Market by Type
  1. 4.1 Cyclin Dependent Kinase 1 Type Introduction
  2. 4.1.1 Milciclib
  3. 4.1.2 CD-650
  4. 4.1.3 AT-7519
  5. 4.1.4 Others
  6. 4.2 Global Cyclin Dependent Kinase 1 Sales by Type
  7. 4.2.1 Global Cyclin Dependent Kinase 1 Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cyclin Dependent Kinase 1 Sales by Type (2021-2032)
  9. 4.2.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cyclin Dependent Kinase 1 Revenue by Type
  11. 4.3.1 Global Cyclin Dependent Kinase 1 Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cyclin Dependent Kinase 1 Revenue by Type (2021-2032)
  13. 4.3.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2021-2032)
5 Cyclin Dependent Kinase 1 Market by Application
  1. 5.1 Cyclin Dependent Kinase 1 Application Introduction
  2. 5.1.1 Relapsed Chronic Lymphocytic Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Gliosarcoma
  5. 5.1.4 Others
  6. 5.2 Global Cyclin Dependent Kinase 1 Sales by Application
  7. 5.2.1 Global Cyclin Dependent Kinase 1 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cyclin Dependent Kinase 1 Sales by Application (2021-2032)
  9. 5.2.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Cyclin Dependent Kinase 1 Revenue by Application
  11. 5.3.1 Global Cyclin Dependent Kinase 1 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cyclin Dependent Kinase 1 Revenue by Application (2021-2032)
  13. 5.3.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2021-2032)
6 Global Cyclin Dependent Kinase 1 Sales by Region
  1. 6.1 Global Cyclin Dependent Kinase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyclin Dependent Kinase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Cyclin Dependent Kinase 1 Sales by Region (2021-2026)
  4. 6.2.2 Global Cyclin Dependent Kinase 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cyclin Dependent Kinase 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cyclin Dependent Kinase 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cyclin Dependent Kinase 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cyclin Dependent Kinase 1 Revenue by Region
  1. 7.1 Global Cyclin Dependent Kinase 1 Revenue by Region
  2. 7.1.1 Global Cyclin Dependent Kinase 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cyclin Dependent Kinase 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Cyclin Dependent Kinase 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cyclin Dependent Kinase 1 Revenue (2021-2032)
  8. 7.2.2 North America Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cyclin Dependent Kinase 1 Revenue (2021-2032)
  11. 7.3.2 Europe Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cyclin Dependent Kinase 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cyclin Dependent Kinase 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cyclin Dependent Kinase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tragara Pharmaceuticals Inc
  2. 8.1.1 Tragara Pharmaceuticals Inc Company Information
  3. 8.1.2 Tragara Pharmaceuticals Inc Business Overview
  4. 8.1.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  6. 8.1.5 Tragara Pharmaceuticals Inc Recent Developments
  7. 8.2 Tiziana Life Sciences Plc
  8. 8.2.1 Tiziana Life Sciences Plc Company Information
  9. 8.2.2 Tiziana Life Sciences Plc Business Overview
  10. 8.2.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio
  12. 8.2.5 Tiziana Life Sciences Plc Recent Developments
  13. 8.3 Presage Biosciences Inc
  14. 8.3.1 Presage Biosciences Inc Company Information
  15. 8.3.2 Presage Biosciences Inc Business Overview
  16. 8.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio
  18. 8.3.5 Presage Biosciences Inc Recent Developments
  19. 8.4 ChoDang Pharm Co Ltd
  20. 8.4.1 ChoDang Pharm Co Ltd Company Information
  21. 8.4.2 ChoDang Pharm Co Ltd Business Overview
  22. 8.4.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio
  24. 8.4.5 ChoDang Pharm Co Ltd Recent Developments
  25. 8.5 Astex Pharmaceuticals Inc
  26. 8.5.1 Astex Pharmaceuticals Inc Company Information
  27. 8.5.2 Astex Pharmaceuticals Inc Business Overview
  28. 8.5.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  30. 8.5.5 Astex Pharmaceuticals Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyclin Dependent Kinase 1 Value Chain Analysis
  2. 9.1.1 Cyclin Dependent Kinase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyclin Dependent Kinase 1 Production Mode & Process
  6. 9.2 Cyclin Dependent Kinase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyclin Dependent Kinase 1 Distributors
  9. 9.2.3 Cyclin Dependent Kinase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst